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AbStTaCt 
The activation of human progelatinase A by other matrix metalloproteinases was studied by following both the loss of its N-terminal propeptide 
and the accompanying increase in the rate of hydrolysis of a synthetic substrate. Activated stromelysin 1 was unable to cause any activation of 
progelatinase A beyond that slowly occuring by autolysis, but an 8 h incubation with activated matrilysin was able to produce 64% of the activity 
generated by incubation with (4-aminophenyhnercuric)acetate (APMA). Wild-type progelatinase A and a mutant proenzyme that cannot become 
active were both cleaved by matrilysin to a lower molecular weight species that had lost the propeptide. This shows that matrilysin activates 
progelatinase A by removing the propeptide in a process that does not require any autolytic cleavages. 
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1. Introduction 
The matrix metalloproteinase (MMP) family partici- 
pate in the turnover of extracellular matrix components 
[l]. They are secreted by connective tissue cells as latent 
precursors that ‘must lose an approximately 80 amino 
acid propeptide from the N-terminus in order to become 
activated. This can be achieved by stepwise autolysis 
induced by organomercurials such as (4-aminophenyl- 
mercuric) acetate (APMA). It is proposed that activation 
in vivo is the result of a two-step mechanism involving 
the removal of the first thirty or so amino acids by a 
serine endoproteinase, followed by an autolytic cleavage 
to remove the remaining portion of the propeptide [2]. 
This mechanism has been demonstrated in vitro for all 
the MMPs except gelatinase A (EC 3.4.24.24; MMP2; 
72kDa gelatinase), which has proved resistant to activa- 
tion by any of the endoproteinases so far tested [3,4]. We 
have recently shown, however, that its entire propeptide 
can be removed by an intermolecular autolytic cleavage 
catalysed by previously activated gelatinase A [5]. The 
reaction only proceeds at an appreciable rate with 
greater than ,uM concentrations of proenzyme but the 
ability of progelatinase A to bind to cell surfaces [6] 
means that localised concentrations might approach this 
level in vivo. In order to initiate this mode of activation 
it is necessary that some active gelatinase A is already 
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Abbreviations: MMP, matrix metalloproteinase; APMA, (4-amino- 
phenyhnercuric)acetate; TIMP-1 and -2, tissue inhibitor of metallopro- 
teinases-1 and 2; proE375A, active site mutant of progelatinase A; 
TPCK, N-tosyl+phenylalanine chloromethyl ketone; PMSF, phen- 
yhnethylsulphonylfluoride; McaPLGLDpaAR, (ir-methoxycoumarin- 
4-yl)acetyl-Pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3 -diaminopro- 
pionyll-Ala-Arg-NH,. 
present. This report describes how it might be generated 
for we show that another MMP, matrilysin (EC 
3.4.24.23; MMP7), is also able to remove the progelati- 
nase A propeptide. 
2. Materials and methods 
2.1. Materials 
Recombinant forms of human progelatinase A, human promatrily- 
sin, human prostromelysin-1, human tissue inhibitor of metallopro- 
teinases-1 (TIMP-I), human TIMP-2 and the active site mutant of 
human progelatinase A, proE375A, were all purified from medium 
conditioned by the relevant transfected mouse myeloma cell line as 
previously described [5,7-l 11. 
2.2. Proenzyme activation 
Maximum progelatinase A activity was generated by the incubation 
of a 1 ,uM solution at 23°C for 4 h in the presence of 1 mM APMA. 
Prostromelysin-1 was activated by incubation with 5 &ml TPCK- 
treated porcine trypsin for 45 min at 37°C. The trypsin was then 
inactivated by the addition of PMSF to 1 mM. Promatrilysin was 
activated by incubation at 53°C for 5 h as previously described [7]. All 
activations were performed in 25 mM Tris-HCl, 30 mM NaCl, 10 mM 
CaCl,, pH 7.5 (Buffer A). Activated gelatinase A and stromelysin-1 
were prepared on the day of assay whilst activated matrilysin was stored 
prior to its use at -70°C. 
2.3. Enzyme assay 
Matrix metalloproteinase activity was assayed by following the in- 
crease in fluorescence that accompanied hydrolysis of the synthetic 
substrate, (7-methoxycoumarin4yl)acetyl-Pro-Leu-Gly-~u-[3-(2,4- 
dinitrophenyl)-L-2,3 diaminopropionyl]~Ala-Arg-NH, (McaPLGLD- 
paAR), as previously described [12,13] and with a gelatinase A concen- 
tration in the assay of 100 pM. Matrilysin and stromelysin 1 are only 
weakly active against this substrate [12]. 
2.4. SDS-PAGE 
Samples were run under non-reducing conditions on either precast 
l&20% polyacrylamide gels (Daichii, Tokyo) or on 10% poly- 
acrylamide gels containing 1 mg/ml gelatin. Samples to be run on the 
gelatin zymograms were prepared without boiling as previously de- 
scribed [13] and any bands of gelatinase activity visual&d according 
to standard procedures [14]. Matrilysin is not active on gelatin zy- 
mograms [ 151. 
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2.5. Protein concentration 
Progelatinase A concentration was determined by absorbance at 280 
nm using E = 122800 M-’ .cn-I. The concentrations of active stromely- 
sin-l and active matrilysin were determined by active site titration with 
known amounts of purified TIMP-2 [7,10]. 
2.6. N-terminal amino acid sequencing 
Proteins were separated by SDS-PAGE run under reducing condi- 
tions using precast 4-2096 polyacrylamide gels (Daichii, Tokyo) and 
transferred to a polyvinylidene difluoride membrane (Immobilon PSQ, 
Millipore). After staining with Ponceau S the relevent bands were ex- 
cised and sequenced on a 470AProtein Sequencer (Applied Biosystems) 
with an on-line 120A HPLC. 
3. Results 
The activation of progelatinase A by either matrilysin 
or stromelysin 1 was followed by measuring the rate of 
hydrolysis of the synthetic substrate McaPLGLDpaAR 
(Fig. 1A). The results demonstrate that, whilst incuba- 
tion with matrilysin caused a significant increase in activ- 
ity, stromelysin 1 was unable to activate progelatinase A 
to a level beyond that observed with no additions. The 
slow rate of background activation is presumably due to 
intermolecular autolysis, catalysed initially by the small 
amount of active gelatinase A that copurities with the 
proenzyme [5]. Increasing the matrilysin concentration 
elevated the maximum observed activity and the rate of 
its attainment but the values still fell short of those ob- 
tained with APMA. This was because gelatinase A is also 
subject to inactivation occurring a rate that is independ- 
ent of proteolysis [5,11]. 
The increase in activity was mirrored by the cleavage 
of the proenzyme to two active, lower molecular weight 
species (Fig. 1B). The major product migrated alongside 
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APMA-activated gelatinase A suggesting that it too was 
produced the removal of the propeptide (amino acids 
l-80 [16]). At the later time points of the matrilysin 
incubation, the second lower molecular weight species 
became visible, This is likely to be a breakdown product 
of activated gelatinase A [13]. Both cleavages were 
caused by MMP activity because they did not occur if the 
0.6 PM matrilysin incubation was performed in the pres- 
ence of 4 ,uM TIMP-1 (results not shown). 
It is conceivable that the processing of progelatinase 
A was entirely due to autolytic cleavages that were some- 
how stimulated by the presence of matrilysin. In order 
to discount this possibility it was necessary to examine 
the effect of activated matrilysin on proE375A; a mutant 
of progelatinase A that cannot become active because a 
catalytically essential glutamic acid residue has been re- 
placed by one that prevents peptide bond hydrolysis [ 111. 
The results in Fig. 2 show that, in the presence of matri- 
lysin, proE375A is cleaved at a rate comparable to that 
of the wild-type proenzyme. The major cleavage product 
was similar to APMA-activated gelatinase A in that it 
migrated at 67 kDa and had the N-terminal amino acid 
sequence YNFFPR [3]. This shows that matrilysin is able 
to hydrolyse the N80-Y81 peptide bond that is also 
cleaved in the autolytic activation of progelatinase A 
[3,5]. Of the minor cleavage products produced, the spe- 
cies migrating at 26 kDa is likely to be the catalytically 
inactive gelatinase A C-terminal domain [17]. In the 1 h 
time point sample there can also be seen a cleavage prod- 
uct that migrates to a position between that of proE375A 
and the 67 kDa species. Insufficient quantities were pro- 
duced for N-terminal sequencing but, because there is a 
Fig. 1. The activation of progelatinase A by matrilysin. (A) Progelatinase A at a concentration of 1 .OpM was incubated at 37°C with either (m) 0.6 PM 
matrilysin, (0) 0.1 ,uM matrilysin, (A) 0.9 PM stromelysin 1 or (0) no additions. At the time points indicated, aliquots from each incubation were 
removed and their activity against McaPLGLDpaAR measured. Background activity due to either matrilysin or stromelysin 1 was subtracted from 
the results, which are presented as a percentage of the activity of APMA-activated gelatinase A [5]. (B) Selected samples from the incubations described 
above were analysed by gelatin zymography. Lanes l-5, samples from the 0.6 PM matrilysin incubation (lane 1, 0 h, lane 2, 1 h; lane 3, 2 h, lane 
4, 4 h; lane 5, 8 h); lane 6, 8 h with no additions; lane 7, 8 h with stromelysin 1; lane 8, APMA-activated gelatinase A. The positions of migration 
of progelatinase A @‘) and gelatinase A lacking the propeptide (A) are as indicated. 
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Fig. 2. Analysis by SDS-PAGE of the action of matrilysin on 
proE375A. ProE375A at a concentration of 4.0 PM in Buffer A was 
incubated at 37°C in the presence of either 0.6 pM matrilysin, 0.9 PM 
stromelysin 1 or with no additions. At various time points, samples 
from each incubation were removed and analysed by non-reduced SDS- 
PAGE. Lanes 1-6, matrilysin incubation (lane 1,O h; lane 2, 1 h; lane 
3,2 h; lane 4,4 h; lane 5,8 h; lane 6,24 h); lane 7,24 h with no additions; 
lane 8,24 h with stromelysin 1. The positions of migration of matrilysin 
(M) and stromelysin (S) are as indicated. 
disulphide bond linking the two ends of the gelatinase A 
C-terminal domain [4,5], it must have been the result of 
a cleavage within the N-terminal propeptide. Activated 
stromelysin 1 produced a significantly smaller amount of 
the 67 kDa species confirming that it is much less able 
to remove the propeptide from progelatinase A. 
4. Discussion 
The results presented in this report demonstrate that, 
unlike all other endoproteinases so far tested, matrilysin 
can activate progelatinase A by cleaving away its 
propeptide. As the propeptide can also be removed by 
autolysis it was expected that other MMPs would also 
be able to catalyse the reaction. The results obtained with 
stromelysin 1, however, show that not all the members 
of this enzyme family possess the specificity of action 
necessary to cause significant activation. 
Matrilysin processed wild-type progelatinase A and 
the mutant at approximately equivalent rates dem- 
onstrating that, at the proenzyme concentration tested, 
little autolytic activation was occurring. It is of interest 
that activation by matrilysin might proceed via the for- 
mation of an intermediate because this sort of stepwise 
mechanism is a hallmark of MMP activation [2]. The 
intermediate was not seen during the activation of wild- 
type progelatinase A but it is likely that in this instance 
the remaining propeptide was more rapidly removed by 
a combination of autolytic and matrilysin activity. It 
must be pointed out that the rate of activation by matri- 
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lysin is still relatively slow, falling well short of that 
obtained with either APMA-induced autolytic activation 
or the activation of other MMPs by serine endopro- 
teinases. Promatrilysin, for example, is fully activated 
within 1 h of trypsin addition at 37°C [7]. 
Progelatinase A can be activated by its incubation with the 
membranes of stimulated fibroblasts [4,9,18]. It is poss- 
ible that matrilysin is involved in this process because the 
stimulation has also been shown to increase matrilysin 
mRNA levels [ 191. Matrilysin might, for example, gener- 
ate the small amount of gelatinase A activity required to 
initiate an autolytic activation. Experiments designed to 
test this hypothesis are currently being performed. 
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